Pediatric Neuro-Oncology Tumor Board Quarterly Series - Past Broadcasts
Pediatric Molecular Tumor Board Series
With the intent to “learn from every child with a brain tumor diagnosis, anywhere in the world”, the Society for Neuro-Oncology’s (SNO) Pediatric Special Interest Track has launched the Pediatric Molecular Tumor Board Series with the objective to advance education on clinical management of pediatric brain tumor patient in the molecular era. The SNO Tumor Board aims has been created to provide a live forum to share clinical expertise and patient-based experiences by bringing together mult-disciplinary clinical experts in pediatric diagnostic imaging, pathology, surgical, radiation oncology, medical oncology and clinical scientists for an in-depth round-table discussion on all aspects of patient care, including medical approaches, use of conventional and novel treatment options based on current clinical and scientific evidence, with a particular focus on challenging pediatric and AYA brain tumor diagnoses. Beyond clinical education, the tumor board aims to improve clinical and translational collaborative dialogue in the global pediatric neuro-oncology community and provide insights and opportunities to facilitate basic, translational, and clinical research. It is hope that such collaborative efforts will fast-track tangible advances in medical management of pediatric brain tumor patients across the world including Low and Middle Income and under-resourced countries.
Pediatric Tumor Board Series Leadership Team
![]() Annie Hwang, MD, PhD The Hospital for Sick Children | ![]() Craig Erker, MD, MS The Dalhousie and IWK Health Center | ![]() Holly Lindsay, MD, MS Texas Children's Hospital |
SNO Support Staff
Shelley Pressley, MBA, CMP, Director of Administration
MeLesa Ritterhouse, RN, Manager of CME & Neuro-Oncology Academy